E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/20/2006 in the Prospect News Biotech Daily.

NovaDel files $16.52 million stock shelf

By Laura Lutz

Des Moines, July 20 - NovaDel Pharma Inc. filed a $16.52 million common stock shelf in an S-3 filing with the Securities and Exchange Commission.

The filing covers 14 million shares.

As of July 1, the company had 49,025,869 outstanding shares of common stock, according to the filing.

NovaDel plans to use the proceeds to clinical trials, research and development, sales and marketing and general and administrative expenses.

NovaDel is a Flemington, N.J.-based pharmaceutical company that develops an oral-spray drug delivery system.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.